Nonnucleoside Reverse Transcriptase Inhibitors Reduce HIV-1 Production from Latently Infected Resting CD4( ) T Cells following Latency Reversal
Jennifer M Zerbato, Gilda Tachedjian, Nicolas Sluis-Cremer
Antimicrobial Agents and Chemotherapy | AMER SOC MICROBIOLOGY | Published : 2017
Awarded by National Institutes of Health award
Awarded by NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
This work was supported by a National Institutes of Health award (R21AI119117) to N.S.-C.